ÎÚÑ»´«Ã½

Unsupported Browser
The ÎÚÑ»´«Ã½ website is not compatible with Internet Explorer 11, IE 11. For the best experience please update your browser.
Menu
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ÎÚÑ»´«Ã½member benefits, participate in College activities, and engage with your ÎÚÑ»´«Ã½colleagues. It's all here.

Become a Member
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ÎÚÑ»´«Ã½member benefits, participate in College activities, and engage with your ÎÚÑ»´«Ã½colleagues. It's all here.

Become a Member
ACS
ÎÚÑ»´«Ã½Brief

De Novo PVT After Liver Transplant Increases Risks of Morbidity, Mortality

April 14, 2026

Although portal vein thrombosis (PVT) is well-characterized in the pretransplant setting, de novo PVT after liver transplantation (LT) remains poorly defined, with little known about its incidence, timing patterns, or impact on long-term outcomes in adult deceased-donor LT. Listen to Drs. Omar Alomar and Natnael Doilicho discuss , which found that de novo PVT can be a significant driver of postoperative morbidity, mortality, and organ rejection, and that closer surveillance and study are needed for this underrecognized complication.